Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHYM. Ratings largely remained positive.
Stocks · News reference
BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $56
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $56.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
Boston Scientific expects a 2026 earnings miss after a cyberattack disrupted global operations. Manufacturing and shipping are recovering.
Boston Scientific shares are trading lower after the company disclosed that it's unlikely to meet its FY26 and Q3 adjusted EPS and net sales growth guidance following a previously announced cybersecurity incident that affected operations.